Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...

Please provide your email address to receive an email when new articles are posted on . The CDC, IDSA and other agencies created updated guidance for treating drug-susceptible and drug-resistant TB.

Tuberculosis remains a public health crisis. The World Health Organization's Global Tuberculosis Report released in November 2024 painted a sobering picture; approximately 8.2 million people were ...

Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are ...

Prescribing information and clinical guidelines showed gaps in TB screening protocols for many recently approved targeted immunotherapies.

A new all-oral six-month treatment regimen is safer and more effective at treating rifampicin-resistant tuberculosis (RR-TB) than the current accepted standard of care, according to results announced ...

A new study in "Nature Medicine" estimates 2 million people are incorrectly told they have TB each year — and clinicians miss ...

Jipmer's regional research significantly influences global TB strategies by linking nutrition with disease progression and ...

Zimbabwe is set to roll out a Shorter, Highly-effective, Oral Regimen for Rifampicin-resistant Tuberculosis (SHORRT therapy) which reduces the length of treatment for Multi-Drug Resistant Tuberculosis ...

Tuberculosis (TB) may last for several months, with treatment. The length of time it takes to cure the condition can vary. It may depend on whether the TB is latent or active. Tuberculosis (TB) is a ...